A recent trial showed its new 2-for-1 injection was more effective on both illnesses than existing individual shots.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
The regulator sees some patents as ploys to keep companies from developing cheaper generic versions of 20 different brand-name drugs.
The popular author and financial advisor weighs in on major market trends of last year, and takes a (speculative) peek ahead.
Many advisors simply don’t have the expertise needed to prepare a firm for the next generation of leadership.
Alico, a major supplier to Tropicana, announced Monday that it is sunsetting its citrus business in the Sunshine State.